Welcome to our dedicated page for National Cinemedia SEC filings (Ticker: NCMI), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
The National CineMedia, Inc. (NCMI) SEC filings page on Stock Titan provides access to the company’s regulatory disclosures, alongside AI-powered summaries that help explain key points in plain language. As the managing member and owner of approximately 100% of National CineMedia, LLC, which operates what it describes as the largest cinema advertising platform in the U.S., NCM’s filings give investors insight into how its theater-based advertising network performs and how management responds to industry conditions.
Among the most closely watched documents are annual reports on Form 10-K and quarterly reports on Form 10-Q. These filings typically include detailed discussions of revenue from national advertising, local and regional advertising, and beverage concessionaire agreements, as well as operating expenses such as theater exhibition fees, selling and marketing costs, and administrative and other costs. They also present operating data on total screens, attendance, and revenue per attendee, which are central to understanding NCM’s business model.
Investors can also review current reports on Form 8-K, where NCM discloses material events. Recent 8-K filings have covered topics such as the acquisition of Spotlight Cinema Networks, quarterly earnings press releases, changes to the board of directors, and executive departures with associated compensation arrangements. These documents help track governance developments, strategic transactions, and short-term financial updates between periodic reports.
For those monitoring insider activity and governance, Forms 3, 4, and 5 (when filed) provide information on equity holdings and transactions by directors, officers, and significant shareholders, while proxy statements (Form DEF 14A) outline board composition, director designation agreements, and executive compensation policies. NCM has, for example, described a Director Designation Agreement with Blantyre Capital Limited in its 8-K filings.
Stock Titan’s platform enhances these filings with AI-generated highlights that point out important changes in revenue composition, non-GAAP measures such as Adjusted OIBDA, capital structure details, and governance updates. Real-time ingestion from EDGAR means new NCMI filings appear quickly, and users can drill into specific forms—10-K, 10-Q, 8-K, and Form 4—to understand how National CineMedia’s cinema advertising operations, exhibitor relationships, and strategic initiatives are reflected in its official disclosures.
Woods Maria VG reported acquisition or exercise transactions in this Form 4 filing.
National CineMedia, Inc. executive Maria VG Woods, EVP and General Counsel, reported receiving a grant of 56,180 restricted stock units. Each unit represents the right to receive one share of the company’s common stock. These restricted stock units will vest in three equal annual installments beginning on February 27, 2027.
Ng Ronnie Y. reported acquisition or exercise transactions in this Form 4 filing.
National CineMedia, Inc. reported that its Chief Financial Officer, Ronnie Y. Ng, received a grant of 98,315 restricted stock units (RSUs). Each RSU represents the right to receive one share of the company’s common stock. These RSUs will vest in three equal annual installments beginning on February 27, 2027.
Lesinski Thomas F. reported acquisition or exercise transactions in this Form 4 filing.
National CineMedia, Inc. director and Chief Executive Officer Thomas F. Lesinski reported receiving a grant of restricted stock units. Each unit represents the right to receive one share of the company’s common stock and is scheduled to vest in three equal annual installments beginning on February 27, 2027.
National CineMedia, Inc. director Joe Marchese reported an acquisition of shares through an equity award vesting. On February 27, 2026, 18,210 restricted stock units were converted at $0.00 per unit into 18,210 shares of common stock. Following this transaction, Marchese held 70,875 shares of National CineMedia common stock directly.
National CineMedia, Inc. director Juliana F. Hill acquired common stock through the vesting of restricted stock units. On this date, 18,210 restricted stock units were converted into 18,210 shares of common stock at a price of $0.00 per share. After this derivative exercise and conversion, Hill directly owned 58,575 shares of National CineMedia common stock.
National CineMedia, Inc. director David Edward Glazek reported an acquisition of shares through the vesting of restricted stock units. On February 27, 2026, 18,210 restricted stock units were exercised and converted into 18,210 shares of common stock at no stated exercise price. Following this derivative conversion, Glazek directly owned 61,720 shares of National CineMedia common stock.
National CineMedia, Inc. director Campbell Kotzman Kelly reported acquiring shares through the vesting of equity awards. On February 27, 2026, 14,026 restricted stock units were exercised or converted, resulting in the acquisition of 14,026 shares of common stock at a stated price of $0.00 per share. Each restricted stock unit represented the right to receive one share of common stock, so this filing reflects equity compensation vesting rather than an open-market purchase or sale.
National CineMedia, Inc. director Nicholas Bell reported the vesting of restricted stock units that converted into common stock. On February 27, 2026, he exercised 18,210 restricted stock units for no cash cost, receiving 18,210 shares of common stock. Following this derivative conversion, Bell directly owns 69,186 shares of National CineMedia common stock.
National CineMedia, Inc. filed an amended current report to correct a data error and to furnish updated fourth quarter and full-year 2025 results. Fourth quarter revenue rose to $93.2 million from $86.3 million, with operating income up to $23.8 million and net income of $29.3 million, or $0.31 per diluted share. Adjusted OIBDA increased to $37.2 million. For 2025, revenue edged up to $243.2 million, while the operating loss narrowed to $13.9 million and net loss improved to $10.6 million, or $0.11 per diluted share, though full-year Adjusted OIBDA declined to $39.1 million. The company declared a $0.03 per-share cash dividend and guided first-quarter 2026 revenue to $32.5–$36.5 million with Adjusted OIBDA between $(13.0) million and $(10.0) million.
NCMI reports a Rule 144 notice for planned sale of Common Stock. The filing lists 49,706 shares tied to Restricted Stock Unit Vesting with a date of 03/02/2026. It also discloses a prior transaction on 12/29/2025 showing 37,847 shares and the value 147,225 on the same row.